1. Home
  2. PROV vs NTHI Comparison

PROV vs NTHI Comparison

Compare PROV & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$18.16

Market Cap

107.4M

Sector

Finance

ML Signal

N/A

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$3.09

Market Cap

106.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROV
NTHI
Founded
1956
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
106.0M
IPO Year
2009
2023

Fundamental Metrics

Financial Performance
Metric
PROV
NTHI
Price
$18.16
$3.09
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
★ $18.50
$17.00
AVG Volume (30 Days)
14.7K
★ 177.7K
Earning Date
10-27-2026
11-13-2026
Dividend Yield
★ 3.11%
N/A
EPS Growth
★ 10.75
N/A
EPS
★ 1.03
N/A
Revenue
N/A
★ $39,990.00
Revenue This Year
$3.36
N/A
Revenue Next Year
$0.24
N/A
P/E Ratio
$17.83
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$14.95
$2.96
52 Week High
$18.99
$12.99

Technical Indicators

Market Signals
Indicator
PROV
NTHI
Relative Strength Index (RSI) 38.50 43.54
Support Level $16.95 $3.03
Resistance Level $18.47 $3.70
Average True Range (ATR) 0.24 0.34
MACD -0.09 0.00
Stochastic Oscillator 5.38 36.84

Price Performance

Historical Comparison
PROV
NTHI

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: